Tere Williams
CEO DUB Therapeutics
Tere Williams is the Co-Founder and CEO of DUB Therapeutics, a biotechnology company leveraging data-driven strategies to advance novel therapeutics. With a strong background in both science and business, she also founded the life sciences consulting firm SIMON|PETRK CO., where she guides early-stage biotech companies and non-profits in product development and science advocacy. Tere completed her PhD in Immunology/Vaccinology at Albert Einstein College of Medicine, building upon her MS in Biomedical Sciences. Her expertise spans preclinical research, business strategy, and community engagement, positioning her at the intersection of scientific innovation and entrepreneurial leadership.
Seminars
The RNAi therapeutics landscape is rapidly evolving, with breakthroughs in delivery, efficacy, and commercialization reshaping investor expectations. Key discussion points will include clinical differentiation, market potential, and exit strategies, offering a reality check on valuation drivers and red flags.
- Prioritizing delivery platform versatility as a key value driver, enabling investors to back RNAi companies with broad therapeutic applicability
- Assessing clinical milestones beyond knockdown efficiency, including durability and patient-centric endpoints, to identify therapies with superior commercial potential
- Balancing platform validation with indication selection for optimal risk/reward, ensuring portfolio companies can attract pharma partnerships or IPO success
